These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24781671)

  • 1. Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel.
    Podaralla S; Alt C; Shankar GN
    AAPS PharmSciTech; 2014 Aug; 15(4):928-38. PubMed ID: 24781671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
    Shankar GN; Alt C
    J Antimicrob Chemother; 2014 Dec; 69(12):3282-93. PubMed ID: 25139839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.
    Timur SS; Şahin A; Aytekin E; Öztürk N; Polat KH; Tezel N; Gürsoy RN; Çalış S
    Pharm Dev Technol; 2018 Mar; 23(3):301-310. PubMed ID: 28503983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal semisolid products: Technological performance considering physiologic parameters.
    Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
    Eur J Pharm Sci; 2017 Nov; 109():556-568. PubMed ID: 28887234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological, mucoadhesive and release properties of pluronic F-127 gel and pluronic F-127/polycarbophil mixed gel systems.
    Tirnaksiz F; Robinson JR
    Pharmazie; 2005 Jul; 60(7):518-23. PubMed ID: 16076078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR; Peters JJ; Katz DF
    J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
    Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
    Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chitosan based vaginal bioadhesive gel formulations for antifungal drugs.
    Senyiğit ZA; Karavana SY; Eraç B; Gürsel O; Limoncu MH; Baloğlu E
    Acta Pharm; 2014 Jun; 64(2):139-56. PubMed ID: 24914716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations.
    Tuğcu-Demiröz F; Acartürk F; Erdoğan D
    Int J Pharm; 2013 Nov; 457(1):25-39. PubMed ID: 24036011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow.
    Lai BE; Xie YQ; Lavine ML; Szeri AJ; Owen DH; Katz DF
    J Pharm Sci; 2008 Feb; 97(2):1030-8. PubMed ID: 17724667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
    Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
    J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive in situ forming gel for oral mucositis pain control.
    Li T; Bao Q; Shen J; Lalla RV; Burgess DJ
    Int J Pharm; 2020 Apr; 580():119238. PubMed ID: 32194210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
    Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
    Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
    Karimunnisa S; Atmaram P
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.
    Wang L; Sassi AB; Patton D; Isaacs C; Moncla BJ; Gupta P; Rohan LC
    Drug Dev Ind Pharm; 2012 Aug; 38(8):995-1007. PubMed ID: 22149387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms.
    Bonferoni MC; Giunchedi P; Scalia S; Rossi S; Sandri G; Caramella C
    AAPS PharmSciTech; 2006; 7(4):104. PubMed ID: 17285750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
    Mahalingam A; Simmons AP; Ugaonkar SR; Watson KM; Dezzutti CS; Rohan LC; Buckheit RW; Kiser PF
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1650-60. PubMed ID: 21245437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
    Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
    J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection.
    Brouwers J; Vermeire K; Schols D; Augustijns P
    Virology; 2008 Sep; 378(2):306-10. PubMed ID: 18606432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.